Persistence and variability of yeast isolations from hospitalized patients. a comparison of results from Rostock and Dresden, Germany;Konstanz und variabilität des hefenachweises bei stationären patienten: ein vergleich der untersuchungsergebnisse von rostock und dresden

Mycoses, Supplement

Volumn 40, Issue 1, 1997, Pages 76-80

  Kaben, Ursula ^a   Blaschke Hellmessen, Renate ^a   Helluig S ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Candida; Change of pathogens; Colonization; Yeast spectrum

Indexed keywords

CANDIDA; CONFERENCE PAPER; HOSPITAL; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; YEAST; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLASSIFICATION; COMPARATIVE STUDY; GERMANY; HOSPITAL PATIENT; ISOLATION AND PURIFICATION; RISK FACTOR;

CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; GERMANY; HUMANS; INPATIENTS; RISK FACTORS;

EID: 0030699128     PISSN: 09437312     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Sugar, A. (1995) Candida -number one nosocomial pathogen by year 2000? Clinical Congress News: 7th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria March 2G.-30. 1995 in: Cambridge Med Publ, UK 7,6-7
2. Wingard.J. R., W. G. Merz, R. Saral (1979) Candida tnpicalu a major pathogen in immuncompromised patients; Ann Intern Med 91,539-543
3. Meunier-Carpentier E, T E. Kiehn, D. Armstrong, (1981) Fungemia in immuncompromised host: changing patterns, antigenemia, high mortality. Am J Med 71,363-370
4. Komshian S.V, A. K-Uwaydah,J. D.Sobel, L. R.Crane( 1989) Fungemia caused by Candida species and Torulopsisglabrala in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome; Rev Infect Dis 11,379-390
5. Jams W. R. and the National Nosocomial Infectious Sunaillance System. Hospital Infections Program, Centers for Disease Control. Nosocomial fungal infections in the United States: National nosocomial Infectious Survaillance (NNIS)),January 1980 April 1990, Presented in the Third International Conference on Nosocomial Infections, Atlanta,July 31-August 3 1990
6. Guinet R.,J. Chans, A. Goullier et al (1983) Fatal septicemia due to amphotericin B-resistant Candida lusitaniae; Clin Microbiol 21, 443-444
7. Hadfield, T. L., M. B Smith, R. E Winn (1987) Mycosis caused by Candida lusitaniae. Rev Infect Dis 9,1006-1012
8. Dick, J. D., B. R. Rosengard, W. G. Merz et al (1985) Fatal disseminated candidiasis due to amphothericin B-resistent Candida guilliermondn; Ann Intern Med 102,67-68
9. Bernhardt H. (1995) Breites Spektrum gegen Erreger-Shift bei Systemmykosen. Mykotrend, Sempera-Service Serie 2
10. Gluckmann, E., H. Esperou-Bourdeau, P. Ribaud, A. Devergie, I. Hirsch, F. Traore, F. Derouin (1993) Pilzinfektionen bei Patienten mit allogener Knochenmarktransplantation; Deutsche Übersetzung aus Cah Oncol 2,167-169
11. Wingard, J. R., W. G. Merz, M. G. Rinaldi, T. R.JohnsonJ. E Karp, R. Saral (1991) Increase in Candida krusei infection among patients with bone marrow transplantion and neutropenia treated prophylactically with fluconazole; N EnglJ Med 325,1274-1277
12. Wingard,J. R. (1994) Changes in the spectrum of fungal infections in bone marrow tranplant patients; Infect Dis Clin Pract 3 (Suppl.2), 83-89
13. Akova, M., H. E. Akalin, Ö. Uzun, D. Gür (1991) Emergence of Candida krusei infections after therapy of oropharyngeal candtdiasis with fluconazole Eur J Clin Microbiol Infect Dis 10,598 (letter)
14. Bignardi, G. E., M. A. Savage, R. Coker, S. G. Davis (1991) Fluconazole and Candida kmsei infection;J Hosp Infect 181,326 (letter)
15. Casasnovas R.-O., D. Caillotet, E. Solary, B. Bonotte, P Chavanet, A. Bonin, P. Camerlynck, H. Guy (1992 ) Prophylactic fluconazole and Candida krusei infections; N EnglJ Med 326,891 (letter)